-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, Shuanghe Tianan Pharmaceutical (Guizhou) Co., Ltd., a holding subsidiary of the company, received the Perindopril Amlodipine (III) “Drug Supplement Application Approval Notice” issued by the State Drug Administration and signed a formal transfer contract to complete the change of marketing license holder for the drug. This drug is used as a single agent for adult patients with insufficient control of hypertension; or as an alternative therapy for primary hypertension whose condition is controlled with a combination of perindopril and amlodipine at the same dose level.

Zhitongcaijing·11/02/2026 09:33:51
Listen to the news
Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, Shuanghe Tianan Pharmaceutical (Guizhou) Co., Ltd., a holding subsidiary of the company, received the Perindopril Amlodipine (III) “Drug Supplement Application Approval Notice” issued by the State Drug Administration and signed a formal transfer contract to complete the change of marketing license holder for the drug. This drug is used as a single agent for adult patients with insufficient control of hypertension; or as an alternative therapy for primary hypertension whose condition is controlled with a combination of perindopril and amlodipine at the same dose level.